Technical Analysis for MYL - Mylan Inc.

Grade Last Price % Change Price Change
grade C 38.87 -2.51% -1.00
MYL closed down 2.51 percent on Friday, March 23, 2018, on 64 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical MYL trend table...

Date Alert Name Type % Chg
Mar 23 Lower Bollinger Band Walk Weakness 0.00%
Mar 23 Multiple of Ten Bearish Other 0.00%
Mar 23 Wide Bands Range Expansion 0.00%
Mar 23 Below Lower BB Weakness 0.00%
Mar 23 Lower Bollinger Band Touch Weakness 0.00%
Mar 23 Oversold Stochastic Weakness 0.00%
Mar 22 180 Bearish Setup Bearish Swing Setup -2.51%
Mar 22 Stochastic Reached Oversold Weakness -2.51%
Mar 22 Multiple of Ten Bearish Other -2.51%
Mar 22 Wide Bands Range Expansion -2.51%

Older signals for MYL ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Mylan Inc. engages in the development, manufacture, marketing, licensing, and distribution of generic and branded generic pharmaceuticals, specialty pharmaceuticals, and active pharmaceutical ingredients (APIs) worldwide. It operates in two segments, Generics and Specialty. The Generics segment primarily develops, manufactures, sells, and distributes generic or branded generic pharmaceutical products in tablet, capsule, and injectable or transdermal patch forms, as well as API. It also focuses on developing APIs with non-infringing processes to partner with manufacturers. This segment serves proprietary and ethical pharmaceutical wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies. The Specialty segment manufactures and sells branded specialty injectable, nebulized, and transdermal products for life-threatening conditions. Its products include EpiPen Auto-Injector to treat severe allergic reactions; and Perforomist Inhalation Solution, a formoterol fumarate inhalation solution for the maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disorder patients. This segment serves pharmaceutical wholesalers and distributors, pharmacies, and healthcare institutions. The company also manufactures and sells injectable products in various therapeutic areas for the hospital setting; supplies APIs for the manufacture of antiretroviral (ARV) drugs to treat HIV/AIDS; offers finished dosage form (FDF) products in the ARV market; and manufactures non-ARV FDF products, as well as focuses on developing, manufacturing, and commercializing dry powder inhaler delivery platform. Mylan Inc. has a strategic collaboration with Pfizer Japan Inc. The company was formerly known as Mylan Laboratories Inc. and changed its name to Mylan Inc. in October 2007. Mylan Inc. was founded in 1961 and is based in Canonsburg, Pennsylvania.
Is MYL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 47.82
52 Week Low 29.39
Average Volume 5,191,924
200-Day Moving Average 38.1964
50-Day Moving Average 42.6212
20-Day Moving Average 41.4155
10-Day Moving Average 41.166
Average True Range 1.2332
ADX 16.49
+DI 17.96
-DI 28.1
Chandelier Exit (Long, 3 ATRs ) 40.4804
Chandelier Exit (Short, 3 ATRs ) 42.4996
Upper Bollinger Band 43.5013
Lower Bollinger Band 39.3297
Percent B (%b) -0.11
BandWidth 10.072557
MACD Line -0.5062
MACD Signal Line -0.2502
MACD Histogram -0.256
Fundamentals Value
Market Cap 20.85 Billion
Num Shares 536 Million
EPS 1.24
Price-to-Earnings (P/E) Ratio 31.35
Price-to-Sales 1.72
Price-to-Book 1.61
PEG Ratio 1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 40.77
Resistance 3 (R3) 40.96 40.51 40.45
Resistance 2 (R2) 40.51 40.03 40.42 40.35
Resistance 1 (R1) 39.69 39.73 39.47 39.50 40.24
Pivot Point 39.25 39.25 39.13 39.15 39.25
Support 1 (S1) 38.43 38.76 38.20 38.24 37.50
Support 2 (S2) 37.98 38.46 37.89 37.39
Support 3 (S3) 37.16 37.98 37.29
Support 4 (S4) 36.97